Back
Evoke Pharma Vs. Eli Lilly and Industry Stock Comparison
Buy
53
EVOK
Evoke Pharma
Last Price:
$5.02
Seasonality Move:
1.96%
Sell
37
LLY
Eli Lilly and
Last Price:
$768.11
Seasonality Move:
3.89%
Buy
53
Evoke Pharma (EVOK)
is a Buy
Is Evoke Pharma a Buy, Sell or Hold?
-
The current Evoke Pharma [EVOK] share price is $5.09. The Score for EVOK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
EVOK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
-
The current Eli Lilly and [LLY] share price is $767.76. The Score for LLY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EVOK Stock Price Chart
What is Evoke Pharma's stock price today?
-
The Evoke Pharma share price today is $5.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EVOK is experiencing slight selling pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $767.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
EVOK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 57.08 | Buy |
Chaikin Money Flow: | -768 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.16 - 4.76) | Buy |
Bollinger Bands (100): | (4.26 - 5.54) | Buy |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.86 | Sell |
Relative Strength Index (14 RSI): | 40.37 | Sell |
Chaikin Money Flow: | -8957052 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (751.18 - 808.5) | Sell |
Bollinger Bands (100): | (795.65 - 929.57) | Sell |
EVOK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.67 | Buy |
20-day SMA: | 4.44 | Buy |
50-day SMA: | 4.97 | Buy |
200-day SMA: | 5.6 | Sell |
8-day EMA: | 4.77 | Buy |
20-day EMA: | 4.63 | Buy |
50-day EMA: | 4.79 | Buy |
200-day EMA: | 6.68 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 776.89 | Sell |
20-day SMA: | 789.47 | Sell |
50-day SMA: | 821.6 | Sell |
200-day SMA: | 837.76 | Sell |
8-day EMA: | 775.9 | Sell |
20-day EMA: | 787.21 | Sell |
50-day EMA: | 814.16 | Sell |
200-day EMA: | 807.66 | Sell |
Evoke Pharma Earnings Growth & EVOK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.86 per share, and an increase next year of $9.47 per share.
Evoke Pharma Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |